CRDL – cardiol therapeutics inc. - class a common shares (US:NASDAQ)
Stock Stats
News
Cardiol Therapeutics (NASDAQ:CRDL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Cardiol Therapeutics (NASDAQ:CRDL) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
Cardiol Therapeutics (NASDAQ:CRDL) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long [Yahoo! Finance]
Cardiol Therapeutics (NASDAQ:CRDL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Form 6-K Cardiol Therapeutics For: Feb 10
Form 6-K Cardiol Therapeutics For: Jan 23
Form SCHEDULE 13G Cardiol Therapeutics Filed by: MMCAP International Inc. SPC
Form 6-K Cardiol Therapeutics For: Jan 26
Form 6-K Cardiol Therapeutics For: Jan 23
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.